Pioneering Study Indicates a Potential Treatment for Corneal Endothelial Disease, Reducing the Need for Corneal Transplants (IMAGE)

Elsevier

Pioneering Study Indicates a Potential Treatment for Corneal Endothelial Disease, Reducing the Need for Corneal Transplants

Caption

Researchers at Harvard Medical School have demonstrated the potent therapeutic effects of administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) through melanocortin receptor agonism, providing compelling evidence for the therapeutic potential of this pathway for a wide array of eye disorders. CEnC, corneal endothelial cells; PBS, phosphate-buffered saline.

Credit

The American Journal of Pathology

Usage Restrictions

Please include attribution.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.